We are live on
!
Find out more
WE
Wealth Effects Portfolio holdings
AUM
$282M
1-Year Est. Return
62.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.44%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
–
Cap. Flow
+$245M
Cap. Flow
% of AUM
101.71%
Top 10 Holdings %
Top 10 Hldgs %
38.78%
Holding
215
New
215
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$21.1M |
| 2 |
Apple
AAPL
|
+$17.2M |
| 3 |
Arrowhead Research
ARWR
|
+$10M |
| 4 |
Amazon
AMZN
|
+$10M |
| 5 |
NVIDIA
NVDA
|
+$7.41M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 26.05% |
| 2 | Healthcare | 24.9% |
| 3 | Communication Services | 10.01% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 6.48% |
Similar funds
SIC
DRD
II
3CP
MFG
TC
UFAC
TPW
Wealth Effects's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Wealth Effects, which disclosed 215 positions worth $241M. Its ten largest holdings account for 39% of the portfolio.
Its largest position is Avadel Pharmaceuticals: 2,305,017 shares worth $18.6M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Communication Services.
- Wealth Effects's largest Q4 2021 buy was Avadel Pharmaceuticals: 2,305,017 shares worth $18.6M.
- Wealth Effects's ten largest holdings make up 39% of its $241M portfolio in Q4 2021.
- Wealth Effects disclosed 215 positions in Q4 2021, its first 13F filing on record.
Based on Wealth Effects's 13F filing for Q4 2021, filed 9 Feb 2022.